Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 16, 2016 - Issue 2
Submit an article Journal homepage
222
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluations

Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin

Alvaro MoralesDepartment of Urology, Queen’s University, Kingston, Ontario, CanadaCorrespondence[email protected]
&
Zvi CohenClinical Research, Telesta Therapeutics Inc., Pointe-Claire, Québec, Canada
Pages 273-283 | Received 05 Nov 2015, Accepted 17 Dec 2015, Published online: 11 Feb 2016

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jasper Crijnen & Theo M. De Reijke. (2018) Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer. Expert Opinion on Emerging Drugs 23:2, pages 135-147.
Read now

Articles from other publishers (13)

Fan Li, Xiang Li, Meng‐Lin Jiang, Chun‐Hua Wang, Gao‐Feng Liu, Zi Yang & Yong Wu. (2023) Research progress into the application of Mycobacterium phlei in veterinary medicine . Veterinary Medicine and Science 9:6, pages 2617-2624.
Crossref
Yaohua Ke, Junmeng Zhu, Yanhong Chu, Lanqi Cen, Yao Fu, Xiangshan Fan, Jingyi Shao, Rutian Li, Lixia Yu, Baorui Liu & Qin Liu. (2022) Bifunctional Fusion Membrane‐Based Hydrogel Enhances Antitumor Potency of Autologous Cancer Vaccines by Activating Dendritic Cells. Advanced Functional Materials 32:29, pages 2201306.
Crossref
Denise U. Putri, Po-Hao Feng, Chiou-Feng Lin, Sofia M. Haryana, Marsetyawan H. N. E. Soesatyo, Kang-Yun Lee & Chia-Li Han. (2022) Proteomic networks associated with tumor-educated macrophage polarization and cytotoxicity potentiated by heat-killed tuberculosis. Scientific Reports 12:1.
Crossref
Alvaro Morales, David Robert Siemens & Madhuri Koti. (2021) At a time of global BCG shortage, attempts at optimizing BCG dose and schedule is no longer the answer. Urologic Oncology: Seminars and Original Investigations 39:2, pages 137-138.
Crossref
Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, Christa M. Lam, Xue Li, Ashish M. Kamat, Peter C. Black & D. Robert Siemens. (2020) Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. European Urology Oncology 3:5, pages 622-630.
Crossref
Katia Pane, Peppino Mirabelli, Luigi Coppola, Ester Illiano, Marco Salvatore & Monica Franzese. (2020) New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis. Frontiers in Chemistry 8.
Crossref
Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala & David AlbalaSanchia S. Goonewardene, Raj Persad, Hanif Motiwala & David Albala. 2020. Management of Non-Muscle Invasive Bladder Cancer. Management of Non-Muscle Invasive Bladder Cancer 255 259 .
Mohit Gupta, Max Kates & Trinity J. Bivalacqua. (2019) Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments. Current Opinion in Oncology 31:3, pages 183-187.
Crossref
Estela Noguera-Ortega & Esther Julián. 2018. Mycobacterium - Research and Development. Mycobacterium - Research and Development.
Jin-Feng Zhong, Wei-Gao Wu, Aseyinjan Tastan, Xiao-Qing Zhang, Bin Wang, Xiao-Peng Tang & Re-Jun Fang. (2018) Effects of an immune stimulant, inactivated Mycobacterium phlei, on the growth performance as well as meat quality of fattening pigs . Animal Science Journal 89:4, pages 703-712.
Crossref
C Mario Filion, Lucas Rodrigues, Chad Johannes & Aleksandar Masic. (2017) The in Vitro and in Vivo Anti-Cancer Potential of Mycobacterium Cell Wall Fraction (MCWF) Against Canine Transitional Cell Carcinoma of the Urinary Bladder. Acta Veterinaria 67:4, pages 477-494.
Crossref
Hideyuki Akaza. (2016) Advancing NMIBC treatment beyond current BCG formulations. Nature Reviews Urology 14:1, pages 12-13.
Crossref
Jennifer M. Mataraza & Philip Gotwals. (2016) Recent advances in immuno-oncology and its application to urological cancers. BJU International 118:4, pages 506-514.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.